Morphic Holding, Inc. (MORF)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:22AM EDT. Market open.
| Previous close | 29.13 |
| Open | 29.48 |
| Bid | 28.34 x 200 |
| Ask | 28.64 x 200 |
| Day's range | 28.50 - 29.48 |
| 52-week range | 19.34 - 63.08 |
| Volume | |
| Avg. volume | 435,937 |
| Market cap | 1.428B |
| Beta (5Y monthly) | 1.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.60 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 56.00 |
GlobeNewswireMorphic to Participate in RBC Capital Markets Global Healthcare Conference
WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Dr. Marc Schegerin, COO and CFO, will take part in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference on Wednesday, May 15th, at 9:00 AM ET. A live webcast of the panel discussion and fireside chat at the RBC Global Healthcare Conference will
Simply Wall St.Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Morphic Holding Inc (MORF) Q1 2024 Earnings: A Detailed Review
Insights into Financial Performance and Strategic Developments
© 2024 Yahoo. All rights reserved.